Litcius/Paper detail

The ACE2 receptor accelerates but is not biochemically required for SARS-CoV-2 membrane fusion

Marcos Cervantes, Tobin Hess, Giorgio Gianini Morbioli, Anjali Sengar, Peter M. Kasson

2023Chemical Science21 citationsDOIOpen Access PDF

Abstract

the ACE2 receptor. Structural evidence suggests that ACE2 may not just serve as an attachment factor but also conformationally activate the SARS-CoV-2 spike protein for membrane fusion. Here, we test that hypothesis directly, using DNA-lipid tethering as a synthetic attachment factor in place of ACE2. We find that SARS-CoV-2 pseudovirus and virus-like particles are capable of membrane fusion without ACE2 if activated with an appropriate protease. Thus, ACE2 is not biochemically required for SARS-CoV-2 membrane fusion. However, addition of soluble ACE2 speeds up the fusion reaction. On a per-spike level, ACE2 appears to promote activation for fusion and then subsequent inactivation if an appropriate protease is not present. Kinetic analysis suggests at least two rate-limiting steps for SARS-CoV-2 membrane fusion, one of which is ACE2 dependent and one of which is not. Since ACE2 serves as a high-affinity attachment factor on human cells, the possibility to replace it with other factors implies a flatter fitness landscape for host adaptation by SARS-CoV-2 and future related coronaviruses.

Topics & Concepts

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Coronavirus disease 2019 (COVID-19)Lipid bilayer fusion2019-20 coronavirus outbreakChemistryReceptorFusionMembraneVirologyComputational biologyCell biologyBiologyBiochemistryMedicineInternal medicineLinguisticsInfectious disease (medical specialty)PhilosophyOutbreakDiseaseSARS-CoV-2 and COVID-19 ResearchCOVID-19 Clinical Research StudiesLong-Term Effects of COVID-19
The ACE2 receptor accelerates but is not biochemically required for SARS-CoV-2 membrane fusion | Litcius